11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bradykinin B1 receptor (B1R) is a G-protein-coupled receptor that is overexpressed in a variety of cancers. B1R is not expressed in healthy tissues, making it an attractive cancer imaging marker. Previously, we reported selective uptake of (68)Ga-P03034 ((68)Ga-DOTA-dPEG2-Lys-Arg-Pro-Hyp-Gly-Cha-Ser-Pro-Leu) in B1R-positive (B1R+) HEK293T::hB1R tumor xenografts in mice. In this study, we compare (68)Ga-P03034 with (68)Ga-labeled P04158 ((68)Ga-DOTA-dPEG2-Lys-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-Igl-Oic) and Z02090 ((68)Ga-DOTA-dPEG2-Lys-Lys-Arg-Pro-Hyp-Gly-Cpg-Ser-D-Tic-Cpg) derived from 2 potent B1R antagonists, B9858 and B9958, respectively, for imaging B1R expression with PET.

          Related collections

          Author and article information

          Journal
          J. Nucl. Med.
          Journal of nuclear medicine : official publication, Society of Nuclear Medicine
          Society of Nuclear Medicine
          1535-5667
          0161-5505
          Apr 2015
          : 56
          : 4
          Affiliations
          [1 ] Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada; and.
          [2 ] Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
          [3 ] Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada.
          [4 ] Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada; and fbenard@bccrc.ca.
          Article
          jnumed.114.152132
          10.2967/jnumed.114.152132
          25745086
          647c0af6-2bb3-4f2f-998d-40f7d111dfaf
          History

          bradykinin B1 receptor,B9858,B9958,antagonist,positron emission tomography

          Comments

          Comment on this article